The purpose of this investigation was to determine the effectiveness of silver sulfadiazine as compared with Aquacel Ag in patients with superficial partial-thickness burns.
Twenty-four subjects who sustained superficial partial-thickness burns who were between the ages of 19 and 53 years with time of injury from 0 to 4 days were randomly assigned into a control group (silver sulfadiazine) and experimental group (Aquacel Ag; ConvaTec, Skillman, New Jersey). Wound measurements were assessed at the time of the initial examination and every 4 days afterward until the area was re-epithelialized 100%. To ensure objectivity, the burn area was measured digitally with the software program by Aspyra (Aspyra LLC; Blue Springs, Missouri) to prevent discrepancies in wound measurements.
Significant differences between the silver sulfadiazine and Aquacel Ag group were noted in pain (silver sulfadiazine: 4.70 ± 2.22, Aquacel Ag: 2.92 ± 1.12) and the number of treatments (silver sulfadiazine: 10.27 ± 7.46, Aquacel Ag: 4.10 ± 1.38).
Utilization of Aquacel Ag in superficial-partial thickness burns could lead to a decrease in the number of treatments required to re-epithelialize burns 100% with less pain as compared with silver sulfadiazine.
The author investigates the effectiveness of silver sulfadiazine as compared with Aquacel Ag in patients with superficial partial-thickness burns.
Douglas D. Yarboro, DPT, CWS, ICLM, is Director of Wound Care Services, Northern Hospital of Surry County in Mount Airy, North Carolina, and is an Adjunct Professor in the Doctor of Physical Therapy Program at Winston-Salem State University and the Physical Therapist Assistant Program at Surry Community College, Dobson, North Carolina.
The author has disclosed that he has no financial relationships related to this article.
Submitted October 30, 2012; accepted January 29, 2013.